For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Marijuana cigarette and placebo capsule SCZ-CUD | 3-5% tetrahydrocannabinol cannabis cigarette smoked immediately prior to the second functional MRI and a placebo capsule (for dronabinol) by mouth taken approximately 2.75 hours prior to the second functional MRI. Marijuana: Smoked plant with THC | 0 | None | 1 | 11 | 9 | 11 | View |
| Dronabinol and placebo cigarette SCZ-CUD | Dronabinol 15mg 3-5% by mouth taken approximately 2.75 hours prior to the second functional MRI and a placebo cigarette (for marijuana) smoked immediately prior to the second functional MRI. Dronabinol: Capsule with THC | 0 | None | 0 | 12 | 9 | 12 | View |
| Placebo cigarette and placebo capsule. SCZ-CUD | Placebo cigarette (for marijuana) smoked immediately prior to the second functional MRI and a placebo capsule (for dronabinol) by mouth taken approximately 2.75 hours prior to the second functional MRI. Placebo: Capsule with no active ingredient | 0 | None | 1 | 11 | 8 | 11 | View |
| SCZ-CUD not randomized | Dual diagnosis of Schizophrenia and Cannabis Use disorder, - Completed Scan 1 but not Randomized | 0 | None | 1 | 8 | 2 | 8 | View |
| Marijuana cigarette and placebo capsule CUD only | CUD only 3-5% tetrahydrocannabinol cannabis cigarette smoked immediately prior to the second functional MRI and a placebo capsule (for dronabinol) by mouth taken approximately 2.75 hours prior to the second functional MRI. Marijuana: Smoked plant | 0 | None | 0 | 17 | 14 | 17 | View |
| Dronabinol and placebo cigarette CUD only | CUD only Dronabinol 15mg 3-5% by mouth taken approximately 2.75 hours prior to the second functional MRI and a placebo cigarette (for marijuana) smoked immediately prior to the second functional MRI. | 0 | None | 0 | 17 | 10 | 17 | View |
| Placebo cigarette and placebo capsule CUD only | CUD only Placebo cigarette (for marijuana) smoked immediately prior to the second functional MRI and a placebo capsule (for dronabinol) by mouth taken approximately 2.75 hours prior to the second functional MRI. | 0 | None | 0 | 17 | 14 | 17 | View |
| Cannabis Use Disorder - CUD Did not randomize | Cannabis Use Disorder (CUD), Completed Scan 1 but not Randomized | 0 | None | 1 | 10 | 5 | 10 | View |
| SCZ only | No drug intervention - Completed Scan 1 and 2 | 0 | None | 2 | 18 | 13 | 18 | View |
| SCZ only - Did not complete Scan 2 | No drug intervention - Completed Scan 1 but not Scan 2 | 0 | None | 0 | 3 | 3 | 3 | View |
| Healthy Control - | No drug intervention - Completed Scan 1 and 2 | 0 | None | 0 | 27 | 14 | 27 | View |
| Healthy Control - Did not complete Scan 2 | No drug intervention - Completed Scan 1 but not Scan 2 | 0 | None | 0 | 4 | 0 | 4 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Psychosis | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Vyvanse Intoxication | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Hallucinations | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Chest Pain | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Hallucinations | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Increased cannabis withdrawal symptoms | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Psychiatric symptoms | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| hypertension | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Dental Issues | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Anxiety in MRI | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Skin irritation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Back, shoulder or neck pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| MRI Finding - Nervous System | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Chest Pain | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Nausea or vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Upper Respiratory Infection | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Hemorrhoids | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Chalazia | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Abnormal EKG | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Lightheaded/Dizzy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Dysesthesia/Parasthesia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Ear pain | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Hemorrhoids | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Hypoglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Skin infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Muscle aches | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| MRI Findings - Vascular | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| MRI Findings - Respiratory | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Swelling of vein | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Other | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |